Celcuity shares skyrocket as breast cancer drug combo shows dramatic Phase 3 success
Shares of Celcuity surged more than 186% on Monday after the biotechnology company reported highly positive topline results from a...
Read moreLatest Post
Fund manager Stephen Yiu likes Rheinmetall stock but won’t buy it: here’s why
Rheinmetall AG (ETR: RHM) has been one of the standout performers in Europe’s defense sector this year, with its stock...
Read more
Morgan Stanley foresees volatility for Match, Bumble in Q2 as turnaround remains elusive
Morgan Stanley on Monday warned that it foresees “elevated volatility in key performance indicators and financial metrics” for online dating...
Read more
William Blair is all praise for Tesla-Samsung partnership but remains dovish on TSLA shares
William Blair analyst Jed Dorsheimer was all praise for Tesla Inc (NASDAQ: TSLA) $16.5 billion chip supply agreement with Samsung...
Read more
Top catalysts for the Nikkei 225 Index this week
The Nikkei 225 Index continued its strong bull run this month, reaching a high of ¥42,030, its highest level since...
Read more
DAX Index analysis ahead of Porsche, Adidas, BMW earnings
The German DAX Index futures jumped by nearly 1% on Monday morning as investors reacted to the upcoming earnings and...
Read more
Top catalysts for the Nifty 50 and Sensex indices this week
The Nifty 50 and Sensex indices remained under pressure on Monday as traders awaited key earnings and macroeconomic events. The...
Read more
CAC 40 Index forecast ahead of Kering, Airbus, Hermes, Renault earnings
The CAC 40 Index futures jumped by over 1% on Monday, reaching a high of €7,930, up from last Friday’s...
Read more
SCHD ETF stock forecast ahead of top news this week
The Schwab US Dividend Equity ETF (SCHD) has remained in a tight range this month. SCHD was trading at $27...
Read more
Sranan Gold
Investor Insight Sranan Gold offers early-stage exposure to a high-impact gold discovery in Suriname’s Guiana Shield, one of the world’s...
Read more
